During the past decade, Allergy and Asthma DTC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy and Asthma DTC" #1 sponsor was "Aerovance, Inc." with 1 trials, followed by "Array BioPharma" with 1 trials sponsored, "Bond Avillion 2 Development LP" with 1 trials sponsored, "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy and Asthma DTC" #1 collaborator was "Parexel" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Allergy and Asthma DTC" are "Asthma" (8 trials) and "Perennial Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Allergy and Asthma DTC" in a lesser frequency.

Most popular intervention types in "Allergy and Asthma DTC" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "0.15% azelastine hydrochloride" (1 trials), "ARRY-502, CRTh2 antagonist; oral" (1 trials), "AS MDI" (1 trials) and "Aerovant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy and Asthma DTC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Allergy and Asthma DTC". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Allergy and Asthma DTC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy and Asthma DTC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".